Genetic testing for better schizophrenia medication
Part of Mental health clinical trials.
This trial is testing whether using a genetic test (pharmacogenomics) can help doctors choose the right antipsychotic medication for people with schizophrenia whose current treatment is not working well or causes side effects. The goal is to find a better medicine match for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of schizophrenia
- You are between 18 and 64 years old
- You are currently receiving psychiatric care (as an inpatient or outpatient)
- Your current antipsychotic medication has caused side effects or not worked well enough
- You do not have a serious brain disease, unstable medical condition, or substance abuse problem
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using brain scans and genetic tests can help choose the best treatment for people early in their schizophrenia. It will check if these biomarkers can predict who will respond better to medication.
This study uses genetic testing plus careful monitoring of medication levels to help adjust antipsychotic treatment for schizophrenia. It may help improve symptoms and reduce side effects by choosing the most suitable medication dose or option.
This study tests if using genetic information can help doctors choose the right mental health medication or dose. It may help find treatments that work better with fewer side effects.
This study compares a personalized medication plan based on your genes versus standard dosing for people with depression, anxiety, or psychosis. It may help your clinician choose a safer or more effective dose or medicine by using pharmacogenomics (gene-informed prescribing).
This study looks at brain chemicals involved in “glutamate” and “GABA” signaling in people with schizophrenia (and separately in healthy volunteers). It may help researchers understand what’s going wrong in the brain and guide future treatments.
This study looks at whether a genetic test can help choose the best antidepressant for you. It aims to make treatment more personalized and effective for people with depression.
Hear when a new Schizophenia Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.